TETRACHEL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tetrachel, and when can generic versions of Tetrachel launch?
Tetrachel is a drug marketed by Angus and is included in one NDA.
The generic ingredient in TETRACHEL is tetracycline hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tetrachel
A generic version of TETRACHEL was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TETRACHEL?
- What are the global sales for TETRACHEL?
- What is Average Wholesale Price for TETRACHEL?
Summary for TETRACHEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| DailyMed Link: | TETRACHEL at DailyMed |
US Patents and Regulatory Information for TETRACHEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angus | TETRACHEL | tetracycline hydrochloride | CAPSULE;ORAL | 060343-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Angus | TETRACHEL | tetracycline hydrochloride | CAPSULE;ORAL | 060343-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
